In the article cited above, a composition error resulted in the omission of references 30–35, and the reference Cusi et al. was listed as reference 30. The reference number for Cusi et al. is 36, and the correct references 30–35 are as follows:
Erratum. Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial. Diabetes Care 2021;44:1334–1343
Wellicht vindt u dit ook interessant
Meld u aan voor de maandelijkse nieuwsbrief
Categorieën
- Aanbevolen door de redactie3
- ADA 201818
- ADA 201931
- ADA 202016
- ADA 202120
- ADA 20222
- ADDRM 201611
- ADDRM 20176
- ADDRM 20188
- ATTD 20199
- ATTD 20209
- ATTD 202212
- Congresnieuws203
- Corona17
- E-learning18
- EASD 201716
- EASD 201852
- EASD 201933
- EASD 202019
- EASD 202123
- EASD 202235
- Geen categorie17
- Korte educatie video's172
- Nascholing1
- Nieuws531
- Opinie2
- Podcasts15
- Proefschrift van de maand6
- Updates1.557
- Verdieping5